pmjТихоокеанский медицинский журналPacific Medical Journal1609-1175TGMUpmj-1122Research ArticleСтатьиБИОЛОГИЧЕСКИ АКТИВНЫЕ ВЕЩЕСТВА ИЗ МОРСКИХ ГИДРОБИОНТОВ - ИСТОЧНИК НОВЫХ ФАРМАЦЕВТИЧЕСКИХ СУБСТАНЦИЙ И ЛЕКАРСТВMARINE HIDROBIONT-DERIVED BIOLOGICALLY ACTIVE SUBSTANCES AS A SOURCE OF NEW PHARMACEUTICAL INGREDIENTS AND DRUGSХотимченкоЮ. С.noemail@neicon.ruKhotimchenkoYu. S.noemail@neicon.ruИнститут биологии моря им. А.В. Жирмунского ДВО РАН; Владивостокский государственный медицинский университетRussian Federation2010280620100259Copyright © Хотимченко Ю.С., Khotimchenko Y.S., 20102010Хотимченко Ю.С., Khotimchenko Y.S.Хотимченко Ю.С., Khotimchenko Y.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.tmj-vgmu.ru/jour/article/view/1122

Marine animals and plants are source of nature-occurring compounds varied by chemical structure and biological activity. These are secondary metabolites. Many of these substances and their synthetic analogues exhibit pharmaceutical properties and may serve as a basis to develop new pharmaceutical substances and drugs. The paper overviews marine objects and derived compounds, pharmaceutical effects, and field of their application in medicine.

ReferencesАдрианов А.В. Современные проблемы изучения морского биологического разнообразия // Биология моря. 2004. Т. 30, № 1. С. 3-19.Адрианов А.В. Современные проблемы изучения морского биологического разнообразия // Биология моря. 2004. Т. 30, № 1. С. 3-19.Воробьев В.В. Создание биоактивных фармакологических субстанций и лекарственных средств из морских гидробионтов // Вестник биотехнол. 2009. Т. 4, № 1. С. 33-38.Воробьев В.В. Создание биоактивных фармакологических субстанций и лекарственных средств из морских гидробионтов // Вестник биотехнол. 2009. Т. 4, № 1. С. 33-38.Гетьман М.А. Большая Фарма. М.: АВС, 2008. 328 с.Гетьман М.А. Большая Фарма. М.: АВС, 2008. 328 с.Романова С.А., Хабенский Б.М. Стратегическая роль отрасли в обеспечении национальной безопасности страны // Ремедиум. 2008. № 4. С. 6-14.Романова С.А., Хабенский Б.М. Стратегическая роль отрасли в обеспечении национальной безопасности страны // Ремедиум. 2008. № 4. С. 6-14.Стоник В.А., Толстиков Г.А. Природные соединения и создание отечественных лекарственных препаратов // Вестник РАН. 2008. Т. 78, № 8. С. 675-687.Стоник В.А., Толстиков Г.А. Природные соединения и создание отечественных лекарственных препаратов // Вестник РАН. 2008. Т. 78, № 8. С. 675-687.Хотимченко Ю.С., Ермак И.М., Бедняк А.Е. и др. Фармакология некрахмальных полисахаридов // Вестник ДВО РАН. 2005. № 1. С. 72-82.Хотимченко Ю.С., Ермак И.М., Бедняк А.Е. и др. Фармакология некрахмальных полисахаридов // Вестник ДВО РАН. 2005. № 1. С. 72-82.Alcaraz M.J., Payб M. Marine sponge metabolites for the control of inflammatory diseases // Curr. Opin. Investig. Drugs. 2006. Vol. 7, No. 11. P. 974-979.Alcaraz M.J., Payб M. Marine sponge metabolites for the control of inflammatory diseases // Curr. Opin. Investig. Drugs. 2006. Vol. 7, No. 11. P. 974-979.D'lncalci M., Jimeno J. Preclinical and clinical results with the natural marine product ET-743 // Expert Opin. Investig. Drugs. 2003. Vol. 12, No. 11. P. 1843-1853.D'lncalci M., Jimeno J. Preclinical and clinical results with the natural marine product ET-743 // Expert Opin. Investig. Drugs. 2003. Vol. 12, No. 11. P. 1843-1853.Fattorusso E., Taglialatela-Scafati O. Marine antimalarials // Marine Drugs. 2009. Vol. 7, No. 2. P. 130-152.Fattorusso E., Taglialatela-Scafati O. Marine antimalarials // Marine Drugs. 2009. Vol. 7, No. 2. P. 130-152.Gochfeld D.J., El Sayed K.A., Yousaf M. et al. Marine natural products as lead anti-HIV agents // Mini Rev. Med. Chem. 2003. Vol. 3, No. 5. P. 401-424.Gochfeld D.J., El Sayed K.A., Yousaf M. et al. Marine natural products as lead anti-HIV agents // Mini Rev. Med. Chem. 2003. Vol. 3, No. 5. P. 401-424.Jha R.K., Zi-rong X. Biomedical compounds from marine organisms // Marine Drugs. 2004. Vol. 2, No. 3. P. 123-146.Jha R.K., Zi-rong X. Biomedical compounds from marine organisms // Marine Drugs. 2004. Vol. 2, No. 3. P. 123-146.Koopmans M., Martens D., Wijffels H. Towards commercial production of sponge medicines // Marine Drugs. 2009. Vol. 7, No. 4. P. 787-802.Koopmans M., Martens D., Wijffels H. Towards commercial production of sponge medicines // Marine Drugs. 2009. Vol. 7, No. 4. P. 787-802.Laport M.S., Santos O.C., Muricy G. Marine sponges: potential sources of new antimicrobial drugs // Curr. Pharm. Biotechnol. 2009. Vol. 10. No. 1. P. 86-105.Laport M.S., Santos O.C., Muricy G. Marine sponges: potential sources of new antimicrobial drugs // Curr. Pharm. Biotechnol. 2009. Vol. 10. No. 1. P. 86-105.Martins R.F., Ramos M.F., Herfindel L. et al. Antimicrobal and cytotoxic assessment of marine cyanobacteria - Synechocystis and Synechococus // Marine Drugs. 2008. Vol. 6, No. 1. P. 1-11.Martins R.F., Ramos M.F., Herfindel L. et al. Antimicrobal and cytotoxic assessment of marine cyanobacteria - Synechocystis and Synechococus // Marine Drugs. 2008. Vol. 6, No. 1. P. 1-11.Martinez A. Marine-derived drugs in neurology // Curr. Opin. Investig. Drugs. 2007. Vol. 8, No. 7. P. 525-530.Martinez A. Marine-derived drugs in neurology // Curr. Opin. Investig. Drugs. 2007. Vol. 8, No. 7. P. 525-530.Mishra B.B., Singh R.K., Srivastava A. et al. Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents // Mini Rev. Med. Chem. 2009. Vol. 9, No. 1. P. 107-123.Mishra B.B., Singh R.K., Srivastava A. et al. Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents // Mini Rev. Med. Chem. 2009. Vol. 9, No. 1. P. 107-123.Molinski T.F., Dalisay D.S., Lievens S.L., Saludes J.P. Drug development from marine natural products // Nat. Rev. Drug Discov. 2009. Vol. 8, No. 1. P. 69-85.Molinski T.F., Dalisay D.S., Lievens S.L., Saludes J.P. Drug development from marine natural products // Nat. Rev. Drug Discov. 2009. Vol. 8, No. 1. P. 69-85.Moore K.S., Wehrli S., Roder H. et al. Squalamine: an aminosterol antibiotic from the shark // Proc. Natl. Acad. Sci. U.S.A. 1993. Vol. 90, No. 4. P. 1354-1358.Moore K.S., Wehrli S., Roder H. et al. Squalamine: an aminosterol antibiotic from the shark // Proc. Natl. Acad. Sci. U.S.A. 1993. Vol. 90, No. 4. P. 1354-1358.Muller W.E.G., Brommer F., Batel R. et al. Molecular biodiversity. Case study: Porifera (sponges) // Naturwissenschaften. 2003. Vol. 90, No. 3. P. 103-120.Muller W.E.G., Brommer F., Batel R. et al. Molecular biodiversity. Case study: Porifera (sponges) // Naturwissenschaften. 2003. Vol. 90, No. 3. P. 103-120.Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years // J. Nat. Prod. 2007. Vol. 70, No. 3. P. 461-477.Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years // J. Nat. Prod. 2007. Vol. 70, No. 3. P. 461-477.Olano C., Mйndez C., Salas J.A. Antitumor compounds from marine actinomycetes // Marine Drugs. 2009. Vol. 7, No. 2. P. 210-248.Olano C., Mйndez C., Salas J.A. Antitumor compounds from marine actinomycetes // Marine Drugs. 2009. Vol. 7, No. 2. P. 210-248.Popov A.M., Novikov V.L., Radchenko O.S., Elyakov G.B. The cytotoxic and antitumor activities of the imidazole alkaloid polycarpin from the ascidian Polycarpa aurata and its synthetic analogues // Dokl. Biochem. Biophys. 2002. Vol. 385. P. 213-218.Popov A.M., Novikov V.L., Radchenko O.S., Elyakov G.B. The cytotoxic and antitumor activities of the imidazole alkaloid polycarpin from the ascidian Polycarpa aurata and its synthetic analogues // Dokl. Biochem. Biophys. 2002. Vol. 385. P. 213-218.Prestegard S.K., Oftedal L., Coyne R.T. et al. Marine benthic diatoms contain compounds able to induce leukemia cell death and modulate blood platelet activity // Marine Drugs. 2009. Vol. 7, No. 4. P. 606-623.Prestegard S.K., Oftedal L., Coyne R.T. et al. Marine benthic diatoms contain compounds able to induce leukemia cell death and modulate blood platelet activity // Marine Drugs. 2009. Vol. 7, No. 4. P. 606-623.Rauck R.L., Wallace M.S., Burton A.W. et a. Intrathecal ziconotide for neuropathic pain: a review // Pain Pract. 2009. Vol. 9, No. 5. P. 327-337.Rauck R.L., Wallace M.S., Burton A.W. et a. Intrathecal ziconotide for neuropathic pain: a review // Pain Pract. 2009. Vol. 9, No. 5. P. 327-337.Sci-Edu. New cancer drug extracted from marine organism // People's Daily. 2000. P. 1-4.Sci-Edu. New cancer drug extracted from marine organism // People's Daily. 2000. P. 1-4.Simmons T.L., Andrianasolo E., McPhail K. et al. Marine natural products as anticancer drugs // Mol. Cancer Ther. 2005. Vol. 4, No. 2. P. 333-342.Simmons T.L., Andrianasolo E., McPhail K. et al. Marine natural products as anticancer drugs // Mol. Cancer Ther. 2005. Vol. 4, No. 2. P. 333-342.Singh R., Sharma M., Joshi P., Rawat D.S. Clinical status of anticancer agents derived from marine sources // Anticancer Agents Med. Chem. 2008. Vol. 8, No. 6. P. 603-617.Singh R., Sharma M., Joshi P., Rawat D.S. Clinical status of anticancer agents derived from marine sources // Anticancer Agents Med. Chem. 2008. Vol. 8, No. 6. P. 603-617.Spolaore P., Joannis-Cassan C., Duran E., Isambert A. Commercial application of microalgae // J. Biosci. Bioeng. 2006. Vol. 101, No. 2. P. 87-96.Spolaore P., Joannis-Cassan C., Duran E., Isambert A. Commercial application of microalgae // J. Biosci. Bioeng. 2006. Vol. 101, No. 2. P. 87-96.Watters M.R. Tropical marine neurotoxins: venoms to drugs // Semin. Neurol. 2005. Vol. 25, No. 3. P. 278-289.Watters M.R. Tropical marine neurotoxins: venoms to drugs // Semin. Neurol. 2005. Vol. 25, No. 3. P. 278-289.Williams P.G. Panning for chemical gold: marine bacteria as a source of new therapeutics // Trends Biotechnol. 2009. Vol. 27, No. 1. P. 45-52.Williams P.G. Panning for chemical gold: marine bacteria as a source of new therapeutics // Trends Biotechnol. 2009. Vol. 27, No. 1. P. 45-52.

The authors declare that there are no conflicts of interest present.